BlackRock Health Valuation
| BME Etf | USD 40.18 0.13 0.32% |
At this time, the entity appears to be fairly valued. BlackRock Health Sciences shows a prevailing Real Value of $39.77 per share. The current price of the entity is $40.18. Our model approximates the value of BlackRock Health Sciences from analyzing the entity fundamentals such as profit margin of 6.84 %, and Return On Equity of 0.0901 as well as examining its technical indicators and probability of bankruptcy.
Price Book 0.8643 | Enterprise Value 561.3 M | Price Sales 66.6509 | Trailing PE 10.2239 | Enterprise Value Revenue 9.6748 |
Fairly Valued
Today
Please note that BlackRock Health's price fluctuation is very steady at this time. Calculation of the real value of BlackRock Health Sciences is based on 3 months time horizon. Increasing BlackRock Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BlackRock etf is determined by what a typical buyer is willing to pay for full or partial control of BlackRock Health Sciences. Since BlackRock Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BlackRock Etf. However, BlackRock Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 40.18 | Real 39.77 | Hype 40.1 | Naive 40.04 |
The real value of BlackRock Etf, also known as its intrinsic value, is the underlying worth of BlackRock Health Sciences ETF, which is reflected in its stock price. It is based on BlackRock Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BlackRock Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BlackRock Health Sciences helps investors to forecast how BlackRock etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BlackRock Health more accurately as focusing exclusively on BlackRock Health's fundamentals will not take into account other important factors: BlackRock Health Total Value Analysis
BlackRock Health Sciences is currently expected to have company total value of 561.3 M with market capitalization of 532.61 M, debt of 60.69 K, and cash on hands of 16.68 K. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the BlackRock Health fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
561.3 M | 532.61 M | 60.69 K | 16.68 K |
BlackRock Health Investor Information
The fund holds all of the assets under management (AUM) in different types of exotic instruments. BlackRock Health Sciences last dividend was 2.556 per share. BlackRock Health Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.BlackRock Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of BlackRock indicates not a very effective usage of assets in February.BlackRock Health Ownership Allocation
The market capitalization of BlackRock Health Sciences is $532.61 Million. Almost 76.95 percent of BlackRock Health outstanding shares are held by general public with 0.61 (percent) owned by insiders and only 22.44 % by other corporate entities. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the entity is less than the current market value, you may not be able generate positive returns on investment in the long run.BlackRock Health Profitability Analysis
The company reported the last year's revenue of 20.41 M. Total Income to common stockholders was 20.02 M with profit before taxes, overhead, and interest of 7.99 M.BlackRock Health Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BlackRock Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BlackRock Health and how it compares across the competition.
About BlackRock Health Valuation
The etf valuation mechanism determines BlackRock Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of BlackRock Health. We calculate exposure to BlackRock Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BlackRock Health's related companies. BlackRock Health's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether BlackRock Health's value is low or high relative to the company's performance and growth projections. Determining the market value of BlackRock Health can be done in different ways, such as multiplying its stock price by its outstanding shares.A single share of BlackRock Health represents a small ownership stake in the entity. As a stockholder of BlackRock, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
BlackRock Health Dividends Analysis For Valuation
There are various types of dividends BlackRock Health can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of BlackRock shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from BlackRock Health Sciences directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When BlackRock pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of BlackRock Health by the value of the dividends paid out.
BlackRock Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as BlackRock Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 13.9 M | |
| Quarterly Earnings Growth Y O Y | 3.062 |
Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.